2021-11-16-世界卫生组织-Cervical_cancer_Belgium_2021_country_profile_1页_63kb

Morbidity and Mortality

• Crude cervical cancer incidence per 100,000 women (2020): 10.9
• Age-standardized cervical cancer incidence per 100,000 women (2020): 7.7
• Cumulative risk of cervical cancer by age 74 (2020): 0.8%
• Cervical cancer deaths (2019): 57,800
• Mortality-to-incidence ratio (2020): 0.37
• Population-based cancer registry exists (2021): Yes

Primary Prevention

• HPV vaccination programme: Exists, coverage among girls aged 9-14 years (2020): 71%
• HPV included in national vaccination programme: Yes, introduced in 2011 for girls by age 15
• Related risk factors: Tobacco use prevalence (women aged 15+ years, 2020): ~24.0%; Condom use data not fully specified; HIV incidence not available

Secondary Prevention Screening

• National screening programme for cervical cancer exists (2021): Yes
• Primary screening test used (2021): Cytology or high-performance test
• Target age range: 25-64 years
• Early detection strengthened at primary health care level: Yes
• Referral system from primary to secondary/tertiary care: Yes

Treatment and Supportive Care

• National guidelines on cervical cancer management exist (2021): Yes
• Cancer resources: Radiotherapy units (per 10,000 cancer patients, 2021): 11; Brachytherapy units: 4; Medical staff variations available
• Palliative care for non-communicable diseases: Generally available in public health system
• Specific resources in 2019 or earlier: Radiation oncologists, radiologists, etc., with varying numbers

WHO Cervical Cancer Elimination Strategy

• Aligns with global targets for 2030, but specific national targets not detailed; profile considers data availability.